Skip to main content
. 2018 Nov 1;26:1–5. doi: 10.1016/j.rmcr.2018.10.025

Table 1.

Table showing lung function testing and parameters for both patients at time points before and after pneumonia. Note, case 2 completed a 6MWD with no breaks, achieving a distance of 490. Thus, no further 6MWD was completed owing to his improved lung function since his last test.

Pre-Pneumonia Post-Pneumonia Absolute change (Post-Pre) % change from baseline
CASE 1
FEV1 (L) (% pred) 0.97 (27) 1.18 (33.7) 0.21 (6.7) 21.65 (24.81)
FVC (L) 3.83 3.27 −0.56 −14.62
VC max (L) 4.23 4.79 0.56 13.24
FEV % VC max 22.93 30.94 8.01 34.93
TLC (L) 10.89 10.69 −0.2 −1.84
RV (L) 6.82 5.89 −0.93 −13.64
RV/TLC (%) 62.65 55.13 −7.52 −12.00
VC (L) 4.07 4.79 0.72 17.69
TLCO [mmol/(min*kPa)] 3.37 4.78 1.41 41.84
KCO [mmol/(min*kPa*L)] 0.54 0.54 0 0.00
VA (L) 6.27 8.78 2.51 40.03
6MWD (m) 120 220 100 83.33
BODE 9 8 −1 −11.11
MMRC dyspnoea scale score 4 4 0 0.00
CAT score 32 29 −3 −9.38
SGRQ
health good poor
symptoms 97.05 89.05 −8 8.92
activity 100 100 0 0.00
impact 84.86 89.41 4.55 5.36
total 91.66 92.6 0.94 1.03
BMI
26.73
22
−4.73
−17.70
CASE 2
FEV1 (L) (% pred) 2.38 (56.6) 4.51 (111) 2.13 (54.4) 89.50 (96.11)
FVC (L) 4.9 6.2 1.3 26.53
VC max (L) 4.9 6.3 1.4 28.57
FEV % VC max 48.59 71.62 23.03 47.40
TLC (L) 8.31 7.77 −0.54 −6.50
RV (L) 3.68 1.76 −1.92 −52.17
RV/TLC (%) 44.23 22.59 −21.64 −48.93
VC (L) 4.64 6.01 1.37 29.53
TLCO [mmol/(min*kPa)] 10.11 10.65 0.54 5.34
KCO [mmol/(min*kPa*L)] 1.82 1.54 −0.28 −15.38
VA 5.56 6.93 1.37 24.64

Jones et al (2014) defined minimal clinically important differences (MCIDs) in COPD as: FEV1 change of 100 ml, health status change by 4 units in the St George's Respiratory Questionnaire (SGRQ) (health improvement giving a reduction in score) and change in exercise capacity as 26 ± 2m in 6 minute walking distance [4].